Posted by ABMN Staff on May 2nd, 2024
BridgeBio Pharma, Inc. (NASDAQ:BBIO – Get Free Report) was the recipient of a large increase in short interest during the month of April. As of April 15th, there was short interest totalling 15,070,000 shares, an increase of...
More of this article »